/PRNewswire/ Strata Oncology, Inc., a precision oncology company advancing molecular indications for cancer therapies, today announced that it has appointed.
Company expands global footprint with opening of US facility and appoints industry veteran Chris Barbazette to lead rapidly growing commercial organization Resolve Biosciences today announced the
/PRNewswire/ Amgen (NASDAQ: AMGN) and Kyowa Kirin Co., Ltd. (TSE: 4151) today announced an agreement to jointly develop and commercialize KHK4083, which is.
Amgen today announced that the U.S. Food and Drug Administration has approved LUMAKRAS ™ for the treatment of adult patients with KRAS G12C-mutated locally advanced or metastatic non-small cell lung cancer as determined by an FDA-approved test, who have received at least one prior systemic therapy. LUMAKRAS has received accelerated approval based on overall response rate and duration of response . Continued .
Amgen To Present At The 2021 Jefferies Healthcare Conference
News provided by
Share this article
Share this article
THOUSAND OAKS, Calif., May 28, 2021 /PRNewswire/ Amgen (NASDAQ:AMGN) will present at the 2021 Jefferies Healthcare Conference at 1:30 p.m. ET on Thursday, June 3, 2021. Murdo Gordon, executive vice president of Global Commercial Operations at Amgen will present at the conference. Live audio of the conference call will be broadcast over the internet simultaneously and will be available to members of the news media, investors and the general public.
The webcast, as with other selected presentations regarding developments in Amgen s business given at certain investor and medical conferences, can be accessed on Amgen s website, www.amgen.com, under Investors. Information regarding presentation times, webcast availability and webcast links are noted on Amgen s Investor Relations Events Calendar. The webcast will be archived and available for replay for at least 90 d